4 Biotechs Ready to Kill the Market in 2018 Post author:Sam Post published:December 28, 2017 Post category:BioPharma A look at a few biotechs which should outperform the market in 2018: Source: BioSpace You Might Also Like Amicus Investors Cheer as the FDA Shaves Four Months Off Its Fabry Drug Review Date February 11, 2018 NovoCure Release: Health Care Service Corporation Issues Positive Coverage Decision For Optune June 4, 2017 Oncolytics Biotech Announces 2017 First Quarter Results May 4, 2017
Amicus Investors Cheer as the FDA Shaves Four Months Off Its Fabry Drug Review Date February 11, 2018
NovoCure Release: Health Care Service Corporation Issues Positive Coverage Decision For Optune June 4, 2017
